The recent challenges in global distribution have highlighted the value of securing essential medications like Ivermectin. Relying on overseas manufacturers exposes countries to considerable vulnerabilities, including delivery delays, expense fluctuations, and even geopolitical concerns. Transitioning towards domestic production of Ivermectin offer